At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Advancing Niacin by Inhibiting FLUSHing: (ANTI-FLUSH)
In Brief
A Phase 4 clinical trial evaluating Quercetin and Placebo for Flushing. Completed, enrolled 17 participants across 2 sites.
Detailed Summary
Niacin, or vitamin B3, is known to improve cholesterol disorders and is the most effective drug to raise HDL, or the "good cholesterol". The use of niacin has been limited because of a peculiar adverse effect referred to as "flushing', which consists of redness, warmth, tingling and burning. A recent animal study suggests that flavonoids may prevent flushing due to niacin better than drugs like aspirin. The ANTI-FLUSH study is being done to assess whether a presently available dietary supplement known as quercetin, which is a flavonoid, can reduce the flushing that occurs with niacin. We will also assess whether using quercetin to prevent flushing from niacin, can improve how niacin lowers cholesterol.
Study Details
Timeline
Interventions
Quercetin 500, 1000, or 2000 mg PO one time
Placebo PO one time